Alkermes (ALKS) Misses Q3 EPS by 1c; Narrows Outlook

Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $252.4 million versus the consensus estimate of $273.78 million.

GUIDANCE:

Alkermes sees FY2022 EPS of $0.15-$0.33, versus prior guidance of $0.09-$0.27 and the consensus of $0.20. Alkermes sees FY2022 revenue of $1.07-1.12 billion, versus prior guidance of $1.05-1.12 billion and the consensus of $1.1 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
• Activist investor presses Xerox to review financial services arm - Bloomberg
• Labcorp acquires MLM Medical Labs to expand lab network